Article
Published 28 Jul 2025
Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees
Borden Ladner Gervais LLP
Your search returned 1,489 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 28 Jul 2025
Les nouvelles lignes directrices du CEPMB sont enfin disponibles
Fasken (French)
Article
Published 21 Jul 2025
The Court Grants An Appeal In Favour Of Psychedelic Assisted Psychotherapy – Toth v. Canada, 2025 FCA 119
McMillan LLP
Article
Published 15 Jul 2025
2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law
Smart & Biggar
Article
Published 11 Jul 2025
Important New Procedural Guidelines From The PMPRB
Aird & McBurney LP
Article
Published 10 Jul 2025
Final Guidelines From Canada's PMPRB: The New Era Begins
Torys LLP
Article
Published 9 Jul 2025
Finalized PMPRB Guidelines Published
Smart & Biggar
Article
Published 9 Jul 2025
At Long Last: The New PMPRB Guidelines Are Here
Fasken
Article
Published 8 Jul 2025
CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary
Smart & Biggar
Article
Published 8 Jul 2025
Closing The Value Gap Using Earnouts In Life Sciences M&A
Aird & Berlis LLP
Article
Published 1 Jul 2025
Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training
Smart & Biggar
Article
Published 30 Jun 2025
Update On Biosimilars In Canada – June 2025
Smart & Biggar
Article
Published 30 Jun 2025
Updated PMPRB Guidelines Expected In Summer 2025 And NPDUIS Releases Ninth Edition Of The Meds Entry Watch Report
Smart & Biggar
Article
Published 26 Jun 2025
La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires
Fasken (French)
Article
Published 25 Jun 2025
Health Canada Consultation On Revised Biosimilar Guidance: No Requirement For Comparative Clinical Efficacy And Safety Trials
Smart & Biggar
Article
Published 20 Jun 2025
Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials
McCarthy Tétrault LLP
Article
Published 5 Jun 2025
Apotex Not Entitled To Damages For Delayed Generic Drug Launch
Tierney Stauffer LLP
Article
Published 30 May 2025
CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments
Smart & Biggar
Article
Published 21 May 2025
Les incidences du projet de loi 83 sur les médecins et le système de santé du Québec
Fasken (French)
Article
Published 16 May 2025
2024 Deal Points Report: Venture Capital Financings
Osler, Hoskin & Harcourt LLP